MedTrace Logo

Amnion Membrane Powder Mohs Study

NCT07680023 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-07-01

No results posted yet for this study

Summary

The purpose of this research study is to test the safety of the amnion membrane powder to see if it improves wound healing in patients undergoing Mohs surgery on the scalp.

Conditions

  • Wound Heal

Interventions

DRUG

Amnion Membrane Powder

amnion membrane power dose of 0.26 mg/mm3 applied during MOHS scalp surgery

DRUG

Standard of Care

aquaphor ointment applied during MOHS scalp surgery

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Christine Ahn, MD · Atrium Health Wake Forest Baptist

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2027-10-31
Completion
2027-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07680023 on ClinicalTrials.gov